Citrus flavonoids and the intestinal barrier: Interactions and effects
- PMID: 33443802
- DOI: 10.1111/1541-4337.12652
Citrus flavonoids and the intestinal barrier: Interactions and effects
Abstract
The intestinal barrier plays a central role in sustaining gut homeostasis and, when dysfunctional, may contribute to diseases. Dietary flavonoids derived from Citrus genus represent one of the main naturally occurring phytochemicals with multiple potential benefits for the intestinal barrier function. In the intestine, citrus flavonoids (CFs) undergo ingestion from the lumen, biotransformation in the epithelial cells and/or crosstalk with luminal microbiota to afford various metabolites that may in turn exert protective actions on gut barrier along with their parental compounds. Specifically, the health-promoting properties of CFs and their metabolic bioactives for the intestinal barrier include their capacity to (a) modulate barrier permeability; (b) protect mucus layer; (c) regulate intestinal immune system; (d) fight against oxidative stress; and (e) positively shape microbiome and metabolome. Notably, local effects of CFs can also generate systemic benefits, for instance, improvement of gut microbial dysbiosis helpful to orchestrate gut homeostasis and leading to alleviation of systemic dysmetabolism. Given the important role of the intestinal barrier in overall health, further understanding of underlying action mechanisms and ultimate health effects of CFs as well as their metabolites on the intestine is of great significance to future application of citrus plants and their bioactives as dietary supplements and/or functional ingredients in medical foods.
Keywords: citrus flavonoids; gut microbiota; health-promoting effect; intestinal barrier; metabolic fate.
© 2020 Institute of Food Technologists®.
Similar articles
-
Flavonoids and the gastrointestinal tract: Local and systemic effects.Mol Aspects Med. 2018 Jun;61:41-49. doi: 10.1016/j.mam.2018.01.001. Epub 2018 Jan 12. Mol Aspects Med. 2018. PMID: 29317252 Review.
-
Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.J Autoimmun. 2018 Aug;92:12-34. doi: 10.1016/j.jaut.2018.05.008. Epub 2018 Jun 1. J Autoimmun. 2018. PMID: 29861127 Review.
-
Gut microbiota-derived metabolites as key mucosal barrier modulators in obesity.World J Gastroenterol. 2021 Sep 7;27(33):5555-5565. doi: 10.3748/wjg.v27.i33.5555. World J Gastroenterol. 2021. PMID: 34588751 Free PMC article. Review.
-
The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.Microbiol Spectr. 2015 Jun;3(3). doi: 10.1128/microbiolspec.MBP-0008-2014. Microbiol Spectr. 2015. PMID: 26185088
-
The Interaction between Flavonoids and Intestinal Microbes: A Review.Foods. 2023 Jan 9;12(2):320. doi: 10.3390/foods12020320. Foods. 2023. PMID: 36673411 Free PMC article. Review.
Cited by
-
Gut Microbiome-Based Therapeutics in Critically Ill Adult Patients-A Narrative Review.Nutrients. 2023 Nov 9;15(22):4734. doi: 10.3390/nu15224734. Nutrients. 2023. PMID: 38004128 Free PMC article. Review.
-
Pure Total Flavonoids From Citrus Protect Against Nonsteroidal Anti-inflammatory Drug-Induced Small Intestine Injury by Promoting Autophagy in vivo and in vitro.Front Pharmacol. 2021 Apr 19;12:622744. doi: 10.3389/fphar.2021.622744. eCollection 2021. Front Pharmacol. 2021. PMID: 33953669 Free PMC article.
-
Citrus Flavonoids Supplementation as an Alternative to Replace Zinc Oxide in Weanling Pigs' Diets Minimizing the Use of Antibiotics.Animals (Basel). 2023 Mar 7;13(6):967. doi: 10.3390/ani13060967. Animals (Basel). 2023. PMID: 36978509 Free PMC article.
-
Phytochemical Compounds as Promising Therapeutics for Intestinal Fibrosis in Inflammatory Bowel Disease: A Critical Review.Nutrients. 2024 Oct 25;16(21):3633. doi: 10.3390/nu16213633. Nutrients. 2024. PMID: 39519465 Free PMC article. Review.
-
The Role of Antioxidant Compounds from Citrus Waste in Modulating Neuroinflammation: A Sustainable Solution.Antioxidants (Basel). 2025 May 11;14(5):581. doi: 10.3390/antiox14050581. Antioxidants (Basel). 2025. PMID: 40427463 Free PMC article. Review.
References
REFERENCES
-
- Abuelsaad, A. S., Mohamed, I., Allam, G., & Al-Solumani, A. A. (2013). Antimicrobial and immunomodulating activities of hesperidin and ellagic acid against diarrheic Aeromonas hydrophila in a murine model. Life Sciences, 93(20), 714-722.
-
- Almeida, A. F., Borge, G. I. A., Piskula, M., Tudose, A., Tudoreanu, L. Valentová, K., … Santos, C. N. (2018). Bioavailability of quercetin in humans with a focus on interindividual variation. Comprehensive Reviews in Food Science & Food Safety, 17(3), 714-731.
-
- Ameer, B., Weintraub, R. A., Johnson, J. V., Yost, R. A., & Rouseff, R. L. (1996). Flavanone absorption after naringin, hesperidin, and citrus administration. Clinical Pharmacology and Therapeutics, 60(1), 34-40.
-
- Anhê, F. F., Pilon, G., Roy, D., Desjardins, Y., Levy, E., & Marette, A. (2016). Triggering Akkermansia with dietary polyphenols: A new weapon to combat the metabolic syndrome? Gut Microbes, 7(2), 146-153.
-
- Aura, A. M., O'Leary, K. A., Williamson, G., Ojala, M., Bailey, M., Puupponen-Pimia, R., … Poutanen, K. (2002). Quercetin derivatives are deconjugated and converted to hydroxyphenylacetic acids but not methylated by human fecal flora in vitro. Journal of Agricultural and Food Chemistry, 50(6), 1725-1730.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources